SlideShare a Scribd company logo
1 of 8
Download to read offline
26 July 2014
1QFY15 Results Update | Sector: Financials
Indian Bank
Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415
Sohail Halai (Sohail.Halai@MotilalOswal.com); +91 22 39825430
BSE SENSEX S&P CNX
CMP: INR156 TP: INR230 Buy26,127 7,790
Bloomberg INBK IN
Equity Shares (m) 464.8
M.Cap. (INR b) / (USD b) 72.5/1.2
52-Week Range (INR) 199/61
1, 6, 12 Rel. Per (%) -16/22/25
Financials & Valuation (INR b)
Y/E Mar 2015E 2016E 2017E
NII 46.1 51.8 60.0
OP 29.6 33.6 38.5
NP 10.9 13.1 14.9
EPS (INR) 23.4 28.1 32.0
EPS Gr. (%) -6.0 19.8 14.0
BV/Sh. INR 266.1 287.7 312.2
P/E (x) 6.7 5.6 4.9
P/BV (x) 0.6 0.5 0.5
RoE (%) 9.1 10.1 10.7
ROA (%) 0.6 0.6 0.6
 Indian Bank’s 1QFY15 reported PAT declined 35% YoY to INR2.1b (31% below
expectation). While NIM was largely stable QoQ at 2.4%, loan growth of 8% YoY
(expectation of 15% YoY) led to 9% below estimated NII of INR10.7b. Weak fees
(23% below est) and high credit cost of 1% (expectation of 0.8%) impacted PAT.
 Slippages were elevated at INR9.4b (annualized slippage ratio of 3.5%) v/s INR8.8b
in 4QFY14. Sale of loans to ARCs of INR5.2b however helped contain GNPA
increase (+4% QoQ). GNPA and NNPA % increased to 4% and 2.5% as compared to
3.7% and 2.3% - led by denominator effect (sequential loan book declined 5%).
PCR (including technical write-off) was stable QoQ at 57.6%.
 Incremental restructuring of INR14.2b of which INR10.7b was on account of power
segment. OSRL stood at 8% of loans. Of the RL, 70% is contributed by Infra (35%
SEB, 5% AI) and 5% each is contributed by Steel and Textiles.
Valuation and view: 1Q reported earnings were significantly below estimate led by
sharp moderation in loan growth (consolidation of its balance-sheet). NIM was stable
QoQ and management remains confident of maintaining/improving it from current
levels. With strong capitalization (CET I of 10.9%), INBK is well poised to benefit from
up-turn in economic growth. INBK asset quality is highly levered to resolution of
Infrastructure related issues and improvement in Steel and textile segment. Valuations
at 0.5x PBV FY15/16 factor negatives. Maintain Buy.
Investors are advised to refer through disclosures made at the end of the Research Report.
26 July 2014 2
Indian Bank
Quarterly Performance: Significantly below estimates
Y/E MARCH 1QFY15A 1QFY15E Var (%) Comments
Net Interest Income 10,720 11,728 -9
NIM and loan growth below expectation
% Change (Y-o-Y) -2 7
Other Income 2,152 2,853 -25 Fees below estimate
Net Income 12,872 14,582 -12
Operating Expenses 6,502 7,234 -10 Employee expense lower than estimate
Operating Profit 6,370 7,348 -13
% Change (Y-o-Y) -26 -14
Other Provisions 3,256 3,067 6 Credit cost remains elevated at 1%
Profit before Tax 3,114 4,281 -27
Tax Provisions 1,042 1,284 -19 Tax rate of 33% v/s expectation of 30%
Net Profit 2,072 2,997 -31
% Change (Y-o-Y) -35 -6
Source: MOSL, Company
GNPA containment helped by sale of loans to ARCs
 During the quarter slippage amounted to INR9.4b (annualized slippage ratio of
3.5%) as compared to INR8.9b in 4QFY14.
 Core upgrades and recoveries of INR1.6b and sale of loans to ARCs of INR5.2b
helped bank to contain GNPA increase (+4% QoQ).
 In percentage terms, GNPA% and NNPA% was at 4% and 2.5% as compared to
3.7% and 2.3% in FY14 – partially led by 5% sequential decline in loans
(denominator effect).
 During the quarter bank restructured loan of INR14.2b (1.2% of loans) of which
increase was led by power segment (a) discoms – INR4.9b and (2) other power
loans INR5.9b. Further, restructuring came in from segments of iron and steel
and textiles at INR1.7b and INR1.2b respectively.
 OSRL portfolio stood at INR93.1b (8% of loans) of which 35% is from SEB, 5%
from Air India, 30% from other Infra and 5% each from Iron and steel and textile
segment
NIM stable QoQ; sequential decline in loan growth impacted NII
 Global NIMs were stable QoQ at 2.4% (domestic NIMs of 2.5%), however loan
growth was significantly lower than expected at 7% YoY (expectation of 15%).
Lower growth led to 9% below estimated NII of INR10.7b.
 Loan growth came in lower on account of sharp moderation in corporate loans
(up just 6% YoY but declined 10% QoQ) and SME loans (up 8% YoY but declined
6% QoQ). Agriculture growth was strong at 7% QoQ and 18% YoY.
Other highlights
 CASA growth moderated to 8% YoY led by nearly flat CA deposits YoY and SA
deposit growth of 9% YoY. However led by shedding of bulk deposits (INR70b
this quarter), CASA ratio improved to 29.2% and 28.3% a quarter ago.
 Fee income came in significantly below estimate at INR1.7b v/s expectation of
INR2.2b and led to lower than expected other income.
 Credit cost for the quarter came in at 1% which led to higher than expected
provisions despite MTM write-back of INR1b.
26 July 2014 3
Indian Bank
Valuation and view
 1Q reported earnings were significantly below estimate led by sharp moderation
in loan growth (consolidation of its balance-sheet). NIM was stable QoQ and
management remains confident of maintaining/improving it from current levels
with expectation of growth improvement.
 INBK asset quality is highly levered to resolution of Infrastructure related issues
and improvement in Steel and textile segment. Almost 80% of restructured
loans and 40% GNPAs are linked to these segments. Thus while gross stress
loans are 13.23% (GNPA 4%+ RL 9.2%), ~70% is contributed by Infra, textiles and
Iron and steel. Adjusting for these gross stress loans are 4.2% of loan book.
 With strong capitalization, bank is well poised to benefit from up-turn in
economic growth as loan growth will resume and asset quality will show
improvement. Valuations of 0.5x PBV FY15/16 factor negatives, Maintain Buy.
One year forward P/BV
Source: MOSL, Company
One year forward P/E
Source: MOSL, Company
DuPont Analysis: Return ratios to show gradual improvement
FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15E FY16E FY17E
NII 3.5 3.3 3.4 3.2 3.4 3.4 3.6 3.4 3.0 2.5 2.4 2.4 2.4
Fee income 0.5 0.3 0.6 0.6 0.7 0.6 0.7 0.6 0.5 0.4 0.4 0.4 0.4
Core Income 3.9 3.6 4.0 3.9 4.1 4.0 4.3 4.0 3.5 2.9 2.7 2.7 2.7
Operating Expenses 2.4 2.5 2.4 2.2 2.1 1.9 1.7 1.7 1.8 1.6 1.5 1.5 1.5
Cost to Core Income Ratio 61.5 68.4 59.4 56.9 50.4 46.2 40.3 41.9 51.9 56.3 55.0 55.3 54.9
- Employee Costs 1.9 1.8 1.7 1.5 1.5 1.3 1.2 1.1 1.3 1.1 0.9 0.9 0.9
- Other Expenses 0.5 0.7 0.7 0.7 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.6 0.6
Core Operating Profit 1.5 1.1 1.6 1.7 2.0 2.2 2.6 2.3 1.7 1.3 1.2 1.2 1.2
Non Core Income 1.0 0.7 1.0 0.9 0.6 0.8 0.4 0.3 0.3 0.4 0.3 0.3 0.3
Operating Profit 2.5 1.9 2.6 2.6 2.7 3.0 3.0 2.6 2.0 1.7 1.5 1.5 1.5
Provisions 1.4 0.8 0.9 0.7 0.3 0.4 0.6 0.9 0.8 0.8 0.7 0.6 0.6
Loan-loss-provisions 0.5 0.2 0.2 0.6 0.0 0.4 0.6 0.6 0.6 0.7 0.6 0.5 0.5
Other provisions 0.9 0.5 0.7 0.1 0.3 (0.0) (0.1) 0.3 0.2 0.2 0.1 0.1 0.1
PBT 1.1 1.1 1.7 1.9 2.3 2.5 2.4 1.7 1.2 0.8 0.8 0.9 0.9
Tax 0.1 0.1 0.2 0.4 0.7 0.9 0.8 0.4 0.2 0.2 0.3 0.3 0.3
ROAA 1.1 1.0 1.5 1.6 1.6 1.7 1.5 1.3 1.0 0.7 0.6 0.6 0.6
Leverage (x) 28.2 26.1 20.4 16.3 15.4 15.3 15.3 15.3 15.5 15.9 16.4 17.1 18.2
ROAE 30.6 26.0 28.4 24.9 24.0 24.9 23.0 19.9 15.7 10.3 9.1 10.1 10.7
Source: MOSL, Company
26 July 2014 4
Indian Bank
Story in charts
Loan growth significantly below estimates
825
864
880
912
939
957
1,000
1,072
1,092
1,107
1,122
1,244
1,177
21
23
19 20
14
11
14
18 16 16
12
16
8
1QFY12
1HFY12
9MFY12
FY12
1QFY13
1HFY13
9MFY13
FY13
1QFY14
1HFY14
9MFY14
FY14
1QFY15
Loans (INR b) YoY Gr. (%)
Source: Company, MOSL
Deposit growth moderates as well
1,104
1,162
1,190
1,208
1,270
1,312
1,351
1,420
1,496
1,527
1,576
1,623
1,553
21
19 18
14 15
13 14
18 18 16 17
14
4
1QFY12
1HFY12
9MFY12
FY12
1QFY13
1HFY13
9MFY13
FY13
1QFY14
1HFY14
9MFY14
FY14
1QFY15
Deposits (INR b) YoY Gr. (%)
Source: Company, MOSL
CASA (calculated) improves QoQ (%)
30.5
29.8
30.2
30.5
29.3
29.0
28.3
27.6
26.9
26.8
26.7
27.2
1QFY12
1HFY12
9MFY12
FY12
1QFY13
1HFY13
9MFY13
FY13
1QFY14
1HFY14
9MFY14
1QFY15
Source: MOSL, Company
Margin stable QoQ but below expectation (%)
3.4
3.8
3.6
3.2
3.3
3.1 3.1
2.9 2.9
2.6 2.7
2.5 2.4
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
Source: MOSL, Company
Slippages remain elevated...
1.7
3.8 2.9 10.4 2.3 7.3 14.2 13.1 6.4 7.7 5.3 8.9 9.4
1.0
2.2
1.6
5.5
1.1
3.4
6.5
5.8
2.8
3.2
2.2
3.4 3.5
1QFY12
2QFY12
3QFY12
4QFY12
1QFY13
2QFY13
3QFY13
4QFY13
1QFY14
2QFY14
3QFY14
4QFY14
1QFY15
Slippages (INR b) Slippage Ratio(%)
Source: MOSL, Company
... but loan sale to ARCs help contain GNPA
1.0
1.2
1.4
2.0
1.7
2.1
3.2
3.3
3.4
3.8
3.4
3.7
4.0
0.5
0.7
0.8
1.3
1.0
1.3
2.2
2.3
2.3
2.6
2.3
2.3
2.548 43 42
35
38 36 33 33 33 33 35
39 40
1QFY12
1HFY12
9MFY12
FY12
1QFY13
1HFY13
9MFY13
FY13
1QFY14
1HFY14
9MFY14
FY14
1QFY15
GNPA (%) NNPA (%) PCR (%)
Source: MOSL, Company
26 July 2014 5
Indian Bank
Quarterly Snapshot
FY13 FY14 FY15 Variation (%)
1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q QoQ YoY
Profit and Loss
Net Interest Income 11,532 11,203 11,434 11,090 10,968 10,937 10,907 10,777 10,720 -1 -2
Other Income 2,227 3,645 2,402 4,589 5,297 2,769 2,426 3,241 2,152 -34 -59
Treasury 223 300 340 1,267 3,144 114 150 405 360 -11 -89
Recovery 341 532 390 718 213 294 500 493 92 -81 -57
Others (Ex non-core) 1,663 2,813 1,672 2,604 1,940 2,361 1,776 2,344 1,700 -27 -12
Total Income 13,759 14,848 13,837 15,678 16,265 13,706 13,332 14,018 12,872 -8 -21
Operating Expenses 5,356 5,764 6,355 10,033 7,672 6,649 7,010 6,984 6,502 -7 -15
Employee 3,691 3,793 4,446 7,808 5,761 4,231 4,863 4,412 4,230 -4 -27
Others 1,665 1,971 1,909 2,224 1,911 2,418 2,146 2,572 2,272 -12 19
Operating Profits 8,402 9,084 7,481 5,646 8,593 7,056 6,323 7,034 6,370 -9 -26
Provisions 1,457 2,022 4,116 4,758 3,681 2,250 2,379 5,939 3,256 -45 -12
PBT 6,945 7,063 3,365 888 4,912 4,807 3,943 1,095 3,114 184 -37
Taxes 2,328 2,096 59 -2,032 1,738 1,749 1,298 -1,618 1,042 -164 -40
PAT 4,617 4,967 3,306 2,919 3,174 3,058 2,645 2,713 2,072 -24 -35
Asset Quality
GNPA 15,539 19,798 31,801 35,655 37,228 41,793 38,348 45,622 47,229 4 27
NNPA 9,631 12,601 21,419 23,843 24,857 28,039 24,836 27,636 28,568 3 15
GNPA (%) 1.7 2.1 3.2 3.3 3.4 3.8 3.4 3.7 4.0 34 60
NNPA (%) 1.0 1.3 2.2 2.3 2.3 2.6 2.3 2.3 2.5 20 15
PCR (Calculated, %) 38 36 33 33 33 33 35 39 40 9 628
PCR (Reported, %) 75 71 61 60 61 59 58 58 58 -21 -369
Ratios (%)
Fees to Total Income 12.1 18.9 12.1 16.6 11.9 17.2 13.3 16.7 13.2
Cost to Core Income 40.6 41.1 48.5 73.3 59.4 50.0 55.3 53.2 52.4
Tax Rate 33.5 29.7 1.8 -228.9 35.4 36.4 32.9 -147.8 33.5
CASA (calculated) 29.3 29.0 28.3 27.6 26.9 26.8 26.7 27.2 27.9
Loan/Deposit 73.9 73.0 74.0 75.5 73.0 72.5 71.2 76.6 75.7
Margins (%) - Reported
Yield on loans 11.3 11.1 11.1 10.6 10.5 10.4 N.A. 10.2 10.1 -8 -36
Cost of Deposits 7.0 7.1 7.1 7.1 7.1 7.1 N.A. 7.1 7.1 0 4
Margins 3.3 3.1 3.1 2.9 2.9 2.6 2.7 2.5 2.4 -3 -44
Balance Sheet (INR b)
Gross Loans 939 957 1,000 1,072 1,092 1,107 1,122 1,244 1,177 -5 8
Deposits 1,270 1,312 1,351 1,420 1,496 1,527 1,576 1,623 1,553 -4 4
CASA Deposits 372 380 383 391 402 409 421 441 433 -2 8
Loan Break Up
Agriculture 142 151 159 170 172 175 178 190 203 7 18
Corporate & Comm Banking 498 495 509 549 553 554 554 646 584 -10 6
Overseas loans 55 55 61 60 66 0 74 75 69 -8 4
Source: MOSL, Company
26 July 2014 6
Indian Bank
EPS: MOSL forecast v/s consensus (INR)
MOSL Consensus Variation
Forecast Forecast (%)
FY15 23.4 31.3 -25.1
FY16 28.1 37.2 -24.5
Shareholding pattern (%)
Jun-14 Mar-14 Jun-13
Promoter 81.5 81.5 80.0
DII 6.5 6.1 6.0
FII 6.9 6.5 8.3
Others 5.1 5.9 5.7
Notes: FII includes depository receipts
Stock performance (1-year)
s
26 July 2014 7
Indian Bank
Financials and valuations
Income Statements (INR Billion)
Y/E March 2014 2015E 2016E 2017E
Interest Income 152.5 169.0 182.6 211.1
Interest Expense 108.9 122.9 130.7 151.1
Net Interest Income 43.6 46.1 51.8 60.0
Change (%) -3.7 5.7 12.5 15.7
Non Interest Income 13.7 12.8 14.9 16.6
Net Income 57.3 58.9 66.7 76.6
Change (%) -1.4 2.7 13.3 14.7
Operating Expenses 28.3 18.6 20.6 23.2
Pre Provision Profits 29.0 40.3 46.2 53.4
Change (%) -5.3 39.0 14.5 15.6
Provisions (excl tax) 14.2 13.4 14.1 16.3
PBT 14.8 26.9 32.1 37.1
Tax 3.2 5.4 6.4 7.3
Tax Rate (%) 21.5 19.9 20.0 19.8
Profits for Equity SH 11.3 10.9 13.1 14.9
Change (%) -26.7 -3.8 19.8 14.0
Equity Dividend (Incl tax) 2.3 2.2 2.6 3.0
Core PPP* 22.0 23.9 26.8 31.3
Change (%) -13.6 8.6 12.1 16.8
Balance Sheet (INR Billion)
Y/E March 2014 2015E 2016E 2017E
Equity Share Capital 4.6 4.6 4.6 4.6
Reserves & Surplus 134.1 141.3 150.1 160.3
Net Worth 138.7 145.9 154.7 165.0
Deposits 1,622.7 1,768.8 2,034.1 2,400.3
Change (%) 14.3 9.0 15.0 18.0
of which CASA Dep 440.6 503.1 574.6 656.5
Change (%) 12.4 14.2 14.2 14.2
Borrowings 49.6 58.4 62.3 66.4
Other Liabilities & Prov. 62.2 74.9 91.1 111.0
Total Liabilities 1,873.3 2,048.0 2,342.2 2,742.6
Current Assets 104.9 100.5 119.2 140.4
Investments 469.1 516.0 577.9 664.6
Change (%) 12.2 10.0 12.0 15.0
Loans 1,222.1 1,344.3 1,545.9 1,824.2
Change (%) 15.7 10.0 15.0 18.0
Fixed Assets 29.3 29.8 30.2 30.7
Other Assets 47.8 57.4 68.9 82.7
Total Assets 1,873.3 2,048.0 2,342.2 2,742.6
Asset Quality (INR Billion)
Y/E March 2014 2015E 2016E 2017E
GNPA 45.6 54.5 58.8 61.1
NNPA 27.6 29.9 30.2 28.8
GNPA Ratio 3.7 4.0 3.7 3.3
NNPA Ratio 2.3 2.2 2.0 1.6
PCR (Excl Tech. write off) 39.4 45.0 48.6 52.8
PCR (Incl Tech. Write off) 57.8 61.0 64.4 68.5
Ratios
Y/E March 2014 2015E 2016E 2017E
Spreads Analysis (%)
Avg. Yield-Earning Assets 9.5 9.4 9.0 9.0
Avg. Yield on loans 10.0 10.0 9.6 9.6
Avg. Yield on Investments 8.4 8.0 7.6 7.5
Avg. Cost-Int. Bear. Liab. 7.0 7.0 6.7 6.6
Avg. Cost of Deposits 7.0 7.0 6.7 6.6
Interest Spread 2.5 2.3 2.4 2.4
Net Interest Margin 2.7 2.6 2.6 2.6
Profitability Ratios (%)
RoE 10.3 9.1 10.1 10.7
RoA 0.7 0.6 0.6 0.6
Int. Expense/Int.Income 71.4 72.7 71.6 71.6
Fee Income/Net Income 14.7 15.1 15.2 15.1
Non Int. Inc./Net Income 23.9 21.8 22.3 21.6
Efficiency Ratios (%)
Cost/Income* 52.9 51.8 51.8 51.7
Empl. Cost/Op. Exps. 68.0 63.5 62.0 60.9
Busi. per Empl. (Rs m) 136.9 145.8 156.2 174.0
NP per Empl. (Rs lac) 6.0 5.3 6.1 6.6
Asset-Liabilty Profile (%)
Loans/Deposit Ratio 75.3 76.0 76.0 76.0
CASA Ratio 27.2 28.4 28.3 27.4
Investment/Deposit Ratio 28.9 29.2 28.4 27.7
G-Sec/Investment Ratio 81.2 82.3 84.5 86.7
CAR 12.6 12.3 11.1 9.9
Tier 1 10.2 10.0 9.1 8.2
Valuation
Y/E March 2014 2015E 2016E 2017E
Book Value (INR) 248.2 266.1 287.7 312.2
Change (%) 2.2 7.2 8.1 8.5
Price-BV (x) 0.6 0.6 0.5 0.5
Adjusted BV (INR) 206.5 221.1 242.2 268.8
Price-ABV (x) 0.8 0.7 0.6 0.6
EPS (Rs) 24.9 23.4 28.1 32.0
Change (%) -32.2 -6.0 19.8 14.0
Price-Earnings (x) 6.3 6.7 5.5 4.9
Dividend Per Share (INR) 4.7 4.7 5.6 6.4
Dividend Yield (%) 3.0 3.0 3.6 4.1
26 July 2014 8
Indian Bank
Disclosures
This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This
report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to
invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been
furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into
account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable
for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and
investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur.
MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business
relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection
processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that
the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may
interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the
profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from
maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an
officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading
strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with
the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and
its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in
any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or
lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its
affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to
hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The
information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the
data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not
intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt
and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its
affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of
its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of
merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations.
Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its
contents.
MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of
Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.
Disclosure of Interest Statement Indian Bank
 Analyst ownership of the stock No
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or
will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible
for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to
law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions.
For U.K.
This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to
which this document relates is only available to investment professionals and will be engaged in only with such persons.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States.
In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state
laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein
are not available to or intended for U.S. persons.
This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional
investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major
institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as
amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has
entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be
executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer,
MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research
analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors
Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore
to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time.
In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited:
Anosh Koppikar Kadambari Balachandran
Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com
Contact(+65)68189232 Contact: (+65) 68189233 / 65249115
Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931
Motilal Oswal Securities Ltd
Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025
Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com

More Related Content

What's hot

Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
IndiaNotes.com
 
Keynote capitals india morning note november 11-'11
Keynote capitals india morning note november 11-'11Keynote capitals india morning note november 11-'11
Keynote capitals india morning note november 11-'11
Keynote Capitals Ltd.
 
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
Amey Sathe, CFA
 
Keynote capitals india morning note april 10-'12
Keynote capitals india morning note april 10-'12Keynote capitals india morning note april 10-'12
Keynote capitals india morning note april 10-'12
Keynote Capitals Ltd.
 
Sib ru2 qfy2011-221010
Sib ru2 qfy2011-221010Sib ru2 qfy2011-221010
Sib ru2 qfy2011-221010
Angel Broking
 
Keynote capitals india morning note april 4-'12
Keynote capitals india morning note april 4-'12Keynote capitals india morning note april 4-'12
Keynote capitals india morning note april 4-'12
Keynote Capitals Ltd.
 
Keynote capitals india morning note april 30-'12
Keynote capitals india morning note april 30-'12Keynote capitals india morning note april 30-'12
Keynote capitals india morning note april 30-'12
Keynote Capitals Ltd.
 

What's hot (20)

Shriram Transport Finance Company Q1FY15: Buy for a target of Rs1130
 Shriram Transport Finance Company Q1FY15: Buy for a target of Rs1130 Shriram Transport Finance Company Q1FY15: Buy for a target of Rs1130
Shriram Transport Finance Company Q1FY15: Buy for a target of Rs1130
 
fundamental analysis for axis bank in banking industry
fundamental analysis for axis bank in banking industryfundamental analysis for axis bank in banking industry
fundamental analysis for axis bank in banking industry
 
Stock Advisory for Today - Natural View on the Stock KPIT Tech
Stock Advisory for Today -  Natural View on the Stock KPIT TechStock Advisory for Today -  Natural View on the Stock KPIT Tech
Stock Advisory for Today - Natural View on the Stock KPIT Tech
 
Ir material 1 q2016 en
Ir material 1 q2016 enIr material 1 q2016 en
Ir material 1 q2016 en
 
Stocks
StocksStocks
Stocks
 
Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
Q4FY14 Result: Bajaj Finance continues to reap the benefits of healthy consum...
 
Keynote capitals india morning note november 11-'11
Keynote capitals india morning note november 11-'11Keynote capitals india morning note november 11-'11
Keynote capitals india morning note november 11-'11
 
R model-portfolio--040821
R model-portfolio--040821R model-portfolio--040821
R model-portfolio--040821
 
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
[JMFL] Repco Home Finance - Initiating Coverage 14 February 14
 
Narnolia Securities Limited: India Equity Analytics Strategy Tips 17th Dec, 2013
Narnolia Securities Limited: India Equity Analytics Strategy Tips 17th Dec, 2013Narnolia Securities Limited: India Equity Analytics Strategy Tips 17th Dec, 2013
Narnolia Securities Limited: India Equity Analytics Strategy Tips 17th Dec, 2013
 
Keynote capitals india morning note april 10-'12
Keynote capitals india morning note april 10-'12Keynote capitals india morning note april 10-'12
Keynote capitals india morning note april 10-'12
 
Sib ru2 qfy2011-221010
Sib ru2 qfy2011-221010Sib ru2 qfy2011-221010
Sib ru2 qfy2011-221010
 
Keynote capitals india morning note april 4-'12
Keynote capitals india morning note april 4-'12Keynote capitals india morning note april 4-'12
Keynote capitals india morning note april 4-'12
 
현대카드 Ir 자료 (2016 2 q) jp
현대카드 Ir 자료 (2016 2 q) jp현대카드 Ir 자료 (2016 2 q) jp
현대카드 Ir 자료 (2016 2 q) jp
 
Investment Funds Advisory for Today: Buy Stock of J&K Bank with Target Price ...
Investment Funds Advisory for Today: Buy Stock of J&K Bank with Target Price ...Investment Funds Advisory for Today: Buy Stock of J&K Bank with Target Price ...
Investment Funds Advisory for Today: Buy Stock of J&K Bank with Target Price ...
 
Keynote capitals india morning note april 30-'12
Keynote capitals india morning note april 30-'12Keynote capitals india morning note april 30-'12
Keynote capitals india morning note april 30-'12
 
2017 1遺꾧린 ir _먮즺_en
2017  1遺꾧린 ir _먮즺_en2017  1遺꾧린 ir _먮즺_en
2017 1遺꾧린 ir _먮즺_en
 
research report
research reportresearch report
research report
 
Asset Reconstruction Company
Asset Reconstruction CompanyAsset Reconstruction Company
Asset Reconstruction Company
 
Investment Funds Advisory Today- Buy Stock of State Bank of India and neutral...
Investment Funds Advisory Today- Buy Stock of State Bank of India and neutral...Investment Funds Advisory Today- Buy Stock of State Bank of India and neutral...
Investment Funds Advisory Today- Buy Stock of State Bank of India and neutral...
 

Viewers also liked

Legal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
Legal shorts 07.02.14, including AIFMD remuneration code and crowdfundingLegal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
Legal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
Cummings
 
Estartegia nacional contra la violencia
Estartegia nacional contra la violenciaEstartegia nacional contra la violencia
Estartegia nacional contra la violencia
Luis Duran
 
Gel co formato informe ejer de rend de ctas_26112012
Gel co formato informe ejer de rend de ctas_26112012Gel co formato informe ejer de rend de ctas_26112012
Gel co formato informe ejer de rend de ctas_26112012
municipiomontebello
 
Convenio 8
Convenio 8Convenio 8
Convenio 8
Irfeyal
 
Aula 09 reengenharia (2)
Aula 09   reengenharia (2)Aula 09   reengenharia (2)
Aula 09 reengenharia (2)
RD COACH
 
Planeacion estrategica
Planeacion estrategicaPlaneacion estrategica
Planeacion estrategica
Luis Duran
 
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
Eduardo Nelson German
 
Direccionamiento estratégico ctcp
Direccionamiento estratégico ctcpDireccionamiento estratégico ctcp
Direccionamiento estratégico ctcp
yannyochoa
 

Viewers also liked (20)

Legal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
Legal shorts 07.02.14, including AIFMD remuneration code and crowdfundingLegal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
Legal shorts 07.02.14, including AIFMD remuneration code and crowdfunding
 
Programación fiestas del toldo y de las flores 2012
Programación fiestas del toldo y de las flores 2012Programación fiestas del toldo y de las flores 2012
Programación fiestas del toldo y de las flores 2012
 
1314
13141314
1314
 
Estartegia nacional contra la violencia
Estartegia nacional contra la violenciaEstartegia nacional contra la violencia
Estartegia nacional contra la violencia
 
Gel co formato informe ejer de rend de ctas_26112012
Gel co formato informe ejer de rend de ctas_26112012Gel co formato informe ejer de rend de ctas_26112012
Gel co formato informe ejer de rend de ctas_26112012
 
Sarai Culturemondo
Sarai CulturemondoSarai Culturemondo
Sarai Culturemondo
 
Oficios
OficiosOficios
Oficios
 
Juegos
JuegosJuegos
Juegos
 
Detection of Highly Pathogenic Avian Influenza outbreak using participatory e...
Detection of Highly Pathogenic Avian Influenza outbreak using participatory e...Detection of Highly Pathogenic Avian Influenza outbreak using participatory e...
Detection of Highly Pathogenic Avian Influenza outbreak using participatory e...
 
Convenio 8
Convenio 8Convenio 8
Convenio 8
 
Aula 09 reengenharia (2)
Aula 09   reengenharia (2)Aula 09   reengenharia (2)
Aula 09 reengenharia (2)
 
Advance Care Planning
Advance Care PlanningAdvance Care Planning
Advance Care Planning
 
CMS Dawn raid team factsheet
CMS Dawn raid team factsheetCMS Dawn raid team factsheet
CMS Dawn raid team factsheet
 
Planeacion estrategica
Planeacion estrategicaPlaneacion estrategica
Planeacion estrategica
 
Kkm ekim 2012
Kkm ekim 2012Kkm ekim 2012
Kkm ekim 2012
 
Retail Investor Trading 2013
Retail Investor Trading 2013Retail Investor Trading 2013
Retail Investor Trading 2013
 
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
Informe por Provincias sobre la Construcción Nº 1, con datos de diciembre y c...
 
LAS NIC NIIF REALIZADO POR MARIA MOLINA
 LAS NIC NIIF REALIZADO POR MARIA MOLINA LAS NIC NIIF REALIZADO POR MARIA MOLINA
LAS NIC NIIF REALIZADO POR MARIA MOLINA
 
Direccionamiento estratégico ctcp
Direccionamiento estratégico ctcpDireccionamiento estratégico ctcp
Direccionamiento estratégico ctcp
 
Curriculum Vitae
Curriculum VitaeCurriculum Vitae
Curriculum Vitae
 

Similar to Indian Bank Q1FY15: Buy for a target of Rs230

Icici bank ru2 qfy2011-291010
Icici bank ru2 qfy2011-291010Icici bank ru2 qfy2011-291010
Icici bank ru2 qfy2011-291010
Angel Broking
 
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 financial results, fundamental, accumulate, analysis, investment, CMP, targe... financial results, fundamental, accumulate, analysis, investment, CMP, targe...
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
IndiaNotes.com
 
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buyCrompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
IndiaNotes.com
 
Indian bank ru2 qfy2011-251010
Indian bank ru2 qfy2011-251010Indian bank ru2 qfy2011-251010
Indian bank ru2 qfy2011-251010
Angel Broking
 
Q3FY15: Buy PTC India for upside 22%, target price 109
Q3FY15: Buy PTC India for upside 22%, target price 109Q3FY15: Buy PTC India for upside 22%, target price 109
Q3FY15: Buy PTC India for upside 22%, target price 109
IndiaNotes.com
 
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
IndiaNotes.com
 
Market outlook 01 11 10
Market outlook 01 11 10Market outlook 01 11 10
Market outlook 01 11 10
Angel Broking
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
IndiaNotes.com
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014
IndiaNotes.com
 
Market outlook 25 10 10
Market outlook 25 10 10Market outlook 25 10 10
Market outlook 25 10 10
Angel Broking
 

Similar to Indian Bank Q1FY15: Buy for a target of Rs230 (20)

DLF Q1FY15: Buy for a a target of Rs252
 DLF Q1FY15: Buy for a a target of Rs252 DLF Q1FY15: Buy for a a target of Rs252
DLF Q1FY15: Buy for a a target of Rs252
 
ING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutral
 
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15 ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
ING Vysya Bank: Sharp deterioration in asset quality impacts NIM in Q1FY15
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buy
 
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buyBajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
Bajaj Finance Q1FY15: AUM growth remained strong at Rs269.4 bn, buy
 
Icici bank ru2 qfy2011-291010
Icici bank ru2 qfy2011-291010Icici bank ru2 qfy2011-291010
Icici bank ru2 qfy2011-291010
 
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 LIC Housing Finance Q1FY15 performance in line with estimates; buy LIC Housing Finance Q1FY15 performance in line with estimates; buy
LIC Housing Finance Q1FY15 performance in line with estimates; buy
 
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 financial results, fundamental, accumulate, analysis, investment, CMP, targe... financial results, fundamental, accumulate, analysis, investment, CMP, targe...
financial results, fundamental, accumulate, analysis, investment, CMP, targe...
 
Q3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upsideQ3FY15: Buy Jain Irrigation for 51% upside
Q3FY15: Buy Jain Irrigation for 51% upside
 
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buyCrompton Greaves 3QFY15 performance remains a mixed bag; buy
Crompton Greaves 3QFY15 performance remains a mixed bag; buy
 
Indian bank ru2 qfy2011-251010
Indian bank ru2 qfy2011-251010Indian bank ru2 qfy2011-251010
Indian bank ru2 qfy2011-251010
 
Q3FY15: Buy PTC India for upside 22%, target price 109
Q3FY15: Buy PTC India for upside 22%, target price 109Q3FY15: Buy PTC India for upside 22%, target price 109
Q3FY15: Buy PTC India for upside 22%, target price 109
 
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
Sobha Developers Q4FY14: Buy for an upgraded target price of Rs540 - Motilal ...
 
Market outlook 01 11 10
Market outlook 01 11 10Market outlook 01 11 10
Market outlook 01 11 10
 
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil FinanceQ2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
Q2FY15: Hold Federal Bank for a target of Rs156 - Sushil Finance
 
TCS: Status quo, on track for revenue acceleration; maintain neutral - Motila...
TCS: Status quo, on track for revenue acceleration; maintain neutral - Motila...TCS: Status quo, on track for revenue acceleration; maintain neutral - Motila...
TCS: Status quo, on track for revenue acceleration; maintain neutral - Motila...
 
Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014Sushil finance indusind_28oct_2014
Sushil finance indusind_28oct_2014
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; hold
 
Market outlook 25 10 10
Market outlook 25 10 10Market outlook 25 10 10
Market outlook 25 10 10
 
Bharti Airtel 1QFY15 revenue above estimates; buy
 Bharti Airtel 1QFY15 revenue above estimates; buy Bharti Airtel 1QFY15 revenue above estimates; buy
Bharti Airtel 1QFY15 revenue above estimates; buy
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 

Recently uploaded

FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
Cocity Enterprises
 
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
samsungultra782445
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
Health
 
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadhabortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
samsungultra782445
 
Economics Presentation-2.pdf xxjshshsjsjsjwjw
Economics Presentation-2.pdf xxjshshsjsjsjwjwEconomics Presentation-2.pdf xxjshshsjsjsjwjw
Economics Presentation-2.pdf xxjshshsjsjsjwjw
mordockmatt25
 
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnLaw of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
TintoTom3
 

Recently uploaded (20)

FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdfFOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
FOREX FUNDAMENTALS: A BEGINNER'S GUIDE.pdf
 
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai MultipleDubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
Dubai Call Girls Deira O525547819 Dubai Call Girls Bur Dubai Multiple
 
Technology industry / Finnish economic outlook
Technology industry / Finnish economic outlookTechnology industry / Finnish economic outlook
Technology industry / Finnish economic outlook
 
Business Principles, Tools, and Techniques in Participating in Various Types...
Business Principles, Tools, and Techniques  in Participating in Various Types...Business Principles, Tools, and Techniques  in Participating in Various Types...
Business Principles, Tools, and Techniques in Participating in Various Types...
 
7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options7 tips trading Deriv Accumulator Options
7 tips trading Deriv Accumulator Options
 
logistics industry development power point ppt.pdf
logistics industry development power point ppt.pdflogistics industry development power point ppt.pdf
logistics industry development power point ppt.pdf
 
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & RequirementsExplore Dual Citizenship in Africa | Citizenship Benefits & Requirements
Explore Dual Citizenship in Africa | Citizenship Benefits & Requirements
 
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammamabortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
abortion pills in Riyadh Saudi Arabia (+919707899604)cytotec pills in dammam
 
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
+97470301568>>buy weed in qatar,buy thc oil in qatar doha>>buy cannabis oil i...
 
Avoidable Errors in Payroll Compliance for Payroll Services Providers - Globu...
Avoidable Errors in Payroll Compliance for Payroll Services Providers - Globu...Avoidable Errors in Payroll Compliance for Payroll Services Providers - Globu...
Avoidable Errors in Payroll Compliance for Payroll Services Providers - Globu...
 
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadhabortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
abortion pills in Jeddah Saudi Arabia (+919707899604)cytotec pills in Riyadh
 
Stock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdfStock Market Brief Deck (Under Pressure).pdf
Stock Market Brief Deck (Under Pressure).pdf
 
Economics Presentation-2.pdf xxjshshsjsjsjwjw
Economics Presentation-2.pdf xxjshshsjsjsjwjwEconomics Presentation-2.pdf xxjshshsjsjsjwjw
Economics Presentation-2.pdf xxjshshsjsjsjwjw
 
fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docx
 
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
Certified Kala Jadu, Black magic specialist in Rawalpindi and Bangali Amil ba...
 
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnLaw of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Law of Demand.pptxnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
 
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
Famous Kala Jadu, Black magic expert in Faisalabad and Kala ilam specialist i...
 
劳伦森大学毕业证
劳伦森大学毕业证劳伦森大学毕业证
劳伦森大学毕业证
 
cost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptxcost-volume-profit analysis.ppt(managerial accounting).pptx
cost-volume-profit analysis.ppt(managerial accounting).pptx
 
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
Female Escorts Service in Hyderabad Starting with 5000/- for Savita Escorts S...
 

Indian Bank Q1FY15: Buy for a target of Rs230

  • 1. 26 July 2014 1QFY15 Results Update | Sector: Financials Indian Bank Alpesh Mehta (Alpesh.Mehta@MotilalOswal.com); +91 22 3982 5415 Sohail Halai (Sohail.Halai@MotilalOswal.com); +91 22 39825430 BSE SENSEX S&P CNX CMP: INR156 TP: INR230 Buy26,127 7,790 Bloomberg INBK IN Equity Shares (m) 464.8 M.Cap. (INR b) / (USD b) 72.5/1.2 52-Week Range (INR) 199/61 1, 6, 12 Rel. Per (%) -16/22/25 Financials & Valuation (INR b) Y/E Mar 2015E 2016E 2017E NII 46.1 51.8 60.0 OP 29.6 33.6 38.5 NP 10.9 13.1 14.9 EPS (INR) 23.4 28.1 32.0 EPS Gr. (%) -6.0 19.8 14.0 BV/Sh. INR 266.1 287.7 312.2 P/E (x) 6.7 5.6 4.9 P/BV (x) 0.6 0.5 0.5 RoE (%) 9.1 10.1 10.7 ROA (%) 0.6 0.6 0.6  Indian Bank’s 1QFY15 reported PAT declined 35% YoY to INR2.1b (31% below expectation). While NIM was largely stable QoQ at 2.4%, loan growth of 8% YoY (expectation of 15% YoY) led to 9% below estimated NII of INR10.7b. Weak fees (23% below est) and high credit cost of 1% (expectation of 0.8%) impacted PAT.  Slippages were elevated at INR9.4b (annualized slippage ratio of 3.5%) v/s INR8.8b in 4QFY14. Sale of loans to ARCs of INR5.2b however helped contain GNPA increase (+4% QoQ). GNPA and NNPA % increased to 4% and 2.5% as compared to 3.7% and 2.3% - led by denominator effect (sequential loan book declined 5%). PCR (including technical write-off) was stable QoQ at 57.6%.  Incremental restructuring of INR14.2b of which INR10.7b was on account of power segment. OSRL stood at 8% of loans. Of the RL, 70% is contributed by Infra (35% SEB, 5% AI) and 5% each is contributed by Steel and Textiles. Valuation and view: 1Q reported earnings were significantly below estimate led by sharp moderation in loan growth (consolidation of its balance-sheet). NIM was stable QoQ and management remains confident of maintaining/improving it from current levels. With strong capitalization (CET I of 10.9%), INBK is well poised to benefit from up-turn in economic growth. INBK asset quality is highly levered to resolution of Infrastructure related issues and improvement in Steel and textile segment. Valuations at 0.5x PBV FY15/16 factor negatives. Maintain Buy. Investors are advised to refer through disclosures made at the end of the Research Report.
  • 2. 26 July 2014 2 Indian Bank Quarterly Performance: Significantly below estimates Y/E MARCH 1QFY15A 1QFY15E Var (%) Comments Net Interest Income 10,720 11,728 -9 NIM and loan growth below expectation % Change (Y-o-Y) -2 7 Other Income 2,152 2,853 -25 Fees below estimate Net Income 12,872 14,582 -12 Operating Expenses 6,502 7,234 -10 Employee expense lower than estimate Operating Profit 6,370 7,348 -13 % Change (Y-o-Y) -26 -14 Other Provisions 3,256 3,067 6 Credit cost remains elevated at 1% Profit before Tax 3,114 4,281 -27 Tax Provisions 1,042 1,284 -19 Tax rate of 33% v/s expectation of 30% Net Profit 2,072 2,997 -31 % Change (Y-o-Y) -35 -6 Source: MOSL, Company GNPA containment helped by sale of loans to ARCs  During the quarter slippage amounted to INR9.4b (annualized slippage ratio of 3.5%) as compared to INR8.9b in 4QFY14.  Core upgrades and recoveries of INR1.6b and sale of loans to ARCs of INR5.2b helped bank to contain GNPA increase (+4% QoQ).  In percentage terms, GNPA% and NNPA% was at 4% and 2.5% as compared to 3.7% and 2.3% in FY14 – partially led by 5% sequential decline in loans (denominator effect).  During the quarter bank restructured loan of INR14.2b (1.2% of loans) of which increase was led by power segment (a) discoms – INR4.9b and (2) other power loans INR5.9b. Further, restructuring came in from segments of iron and steel and textiles at INR1.7b and INR1.2b respectively.  OSRL portfolio stood at INR93.1b (8% of loans) of which 35% is from SEB, 5% from Air India, 30% from other Infra and 5% each from Iron and steel and textile segment NIM stable QoQ; sequential decline in loan growth impacted NII  Global NIMs were stable QoQ at 2.4% (domestic NIMs of 2.5%), however loan growth was significantly lower than expected at 7% YoY (expectation of 15%). Lower growth led to 9% below estimated NII of INR10.7b.  Loan growth came in lower on account of sharp moderation in corporate loans (up just 6% YoY but declined 10% QoQ) and SME loans (up 8% YoY but declined 6% QoQ). Agriculture growth was strong at 7% QoQ and 18% YoY. Other highlights  CASA growth moderated to 8% YoY led by nearly flat CA deposits YoY and SA deposit growth of 9% YoY. However led by shedding of bulk deposits (INR70b this quarter), CASA ratio improved to 29.2% and 28.3% a quarter ago.  Fee income came in significantly below estimate at INR1.7b v/s expectation of INR2.2b and led to lower than expected other income.  Credit cost for the quarter came in at 1% which led to higher than expected provisions despite MTM write-back of INR1b.
  • 3. 26 July 2014 3 Indian Bank Valuation and view  1Q reported earnings were significantly below estimate led by sharp moderation in loan growth (consolidation of its balance-sheet). NIM was stable QoQ and management remains confident of maintaining/improving it from current levels with expectation of growth improvement.  INBK asset quality is highly levered to resolution of Infrastructure related issues and improvement in Steel and textile segment. Almost 80% of restructured loans and 40% GNPAs are linked to these segments. Thus while gross stress loans are 13.23% (GNPA 4%+ RL 9.2%), ~70% is contributed by Infra, textiles and Iron and steel. Adjusting for these gross stress loans are 4.2% of loan book.  With strong capitalization, bank is well poised to benefit from up-turn in economic growth as loan growth will resume and asset quality will show improvement. Valuations of 0.5x PBV FY15/16 factor negatives, Maintain Buy. One year forward P/BV Source: MOSL, Company One year forward P/E Source: MOSL, Company DuPont Analysis: Return ratios to show gradual improvement FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15E FY16E FY17E NII 3.5 3.3 3.4 3.2 3.4 3.4 3.6 3.4 3.0 2.5 2.4 2.4 2.4 Fee income 0.5 0.3 0.6 0.6 0.7 0.6 0.7 0.6 0.5 0.4 0.4 0.4 0.4 Core Income 3.9 3.6 4.0 3.9 4.1 4.0 4.3 4.0 3.5 2.9 2.7 2.7 2.7 Operating Expenses 2.4 2.5 2.4 2.2 2.1 1.9 1.7 1.7 1.8 1.6 1.5 1.5 1.5 Cost to Core Income Ratio 61.5 68.4 59.4 56.9 50.4 46.2 40.3 41.9 51.9 56.3 55.0 55.3 54.9 - Employee Costs 1.9 1.8 1.7 1.5 1.5 1.3 1.2 1.1 1.3 1.1 0.9 0.9 0.9 - Other Expenses 0.5 0.7 0.7 0.7 0.6 0.6 0.5 0.5 0.5 0.5 0.5 0.6 0.6 Core Operating Profit 1.5 1.1 1.6 1.7 2.0 2.2 2.6 2.3 1.7 1.3 1.2 1.2 1.2 Non Core Income 1.0 0.7 1.0 0.9 0.6 0.8 0.4 0.3 0.3 0.4 0.3 0.3 0.3 Operating Profit 2.5 1.9 2.6 2.6 2.7 3.0 3.0 2.6 2.0 1.7 1.5 1.5 1.5 Provisions 1.4 0.8 0.9 0.7 0.3 0.4 0.6 0.9 0.8 0.8 0.7 0.6 0.6 Loan-loss-provisions 0.5 0.2 0.2 0.6 0.0 0.4 0.6 0.6 0.6 0.7 0.6 0.5 0.5 Other provisions 0.9 0.5 0.7 0.1 0.3 (0.0) (0.1) 0.3 0.2 0.2 0.1 0.1 0.1 PBT 1.1 1.1 1.7 1.9 2.3 2.5 2.4 1.7 1.2 0.8 0.8 0.9 0.9 Tax 0.1 0.1 0.2 0.4 0.7 0.9 0.8 0.4 0.2 0.2 0.3 0.3 0.3 ROAA 1.1 1.0 1.5 1.6 1.6 1.7 1.5 1.3 1.0 0.7 0.6 0.6 0.6 Leverage (x) 28.2 26.1 20.4 16.3 15.4 15.3 15.3 15.3 15.5 15.9 16.4 17.1 18.2 ROAE 30.6 26.0 28.4 24.9 24.0 24.9 23.0 19.9 15.7 10.3 9.1 10.1 10.7 Source: MOSL, Company
  • 4. 26 July 2014 4 Indian Bank Story in charts Loan growth significantly below estimates 825 864 880 912 939 957 1,000 1,072 1,092 1,107 1,122 1,244 1,177 21 23 19 20 14 11 14 18 16 16 12 16 8 1QFY12 1HFY12 9MFY12 FY12 1QFY13 1HFY13 9MFY13 FY13 1QFY14 1HFY14 9MFY14 FY14 1QFY15 Loans (INR b) YoY Gr. (%) Source: Company, MOSL Deposit growth moderates as well 1,104 1,162 1,190 1,208 1,270 1,312 1,351 1,420 1,496 1,527 1,576 1,623 1,553 21 19 18 14 15 13 14 18 18 16 17 14 4 1QFY12 1HFY12 9MFY12 FY12 1QFY13 1HFY13 9MFY13 FY13 1QFY14 1HFY14 9MFY14 FY14 1QFY15 Deposits (INR b) YoY Gr. (%) Source: Company, MOSL CASA (calculated) improves QoQ (%) 30.5 29.8 30.2 30.5 29.3 29.0 28.3 27.6 26.9 26.8 26.7 27.2 1QFY12 1HFY12 9MFY12 FY12 1QFY13 1HFY13 9MFY13 FY13 1QFY14 1HFY14 9MFY14 1QFY15 Source: MOSL, Company Margin stable QoQ but below expectation (%) 3.4 3.8 3.6 3.2 3.3 3.1 3.1 2.9 2.9 2.6 2.7 2.5 2.4 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 Source: MOSL, Company Slippages remain elevated... 1.7 3.8 2.9 10.4 2.3 7.3 14.2 13.1 6.4 7.7 5.3 8.9 9.4 1.0 2.2 1.6 5.5 1.1 3.4 6.5 5.8 2.8 3.2 2.2 3.4 3.5 1QFY12 2QFY12 3QFY12 4QFY12 1QFY13 2QFY13 3QFY13 4QFY13 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 Slippages (INR b) Slippage Ratio(%) Source: MOSL, Company ... but loan sale to ARCs help contain GNPA 1.0 1.2 1.4 2.0 1.7 2.1 3.2 3.3 3.4 3.8 3.4 3.7 4.0 0.5 0.7 0.8 1.3 1.0 1.3 2.2 2.3 2.3 2.6 2.3 2.3 2.548 43 42 35 38 36 33 33 33 33 35 39 40 1QFY12 1HFY12 9MFY12 FY12 1QFY13 1HFY13 9MFY13 FY13 1QFY14 1HFY14 9MFY14 FY14 1QFY15 GNPA (%) NNPA (%) PCR (%) Source: MOSL, Company
  • 5. 26 July 2014 5 Indian Bank Quarterly Snapshot FY13 FY14 FY15 Variation (%) 1Q 2Q 3Q 4Q 1Q 2Q 3Q 4Q 1Q QoQ YoY Profit and Loss Net Interest Income 11,532 11,203 11,434 11,090 10,968 10,937 10,907 10,777 10,720 -1 -2 Other Income 2,227 3,645 2,402 4,589 5,297 2,769 2,426 3,241 2,152 -34 -59 Treasury 223 300 340 1,267 3,144 114 150 405 360 -11 -89 Recovery 341 532 390 718 213 294 500 493 92 -81 -57 Others (Ex non-core) 1,663 2,813 1,672 2,604 1,940 2,361 1,776 2,344 1,700 -27 -12 Total Income 13,759 14,848 13,837 15,678 16,265 13,706 13,332 14,018 12,872 -8 -21 Operating Expenses 5,356 5,764 6,355 10,033 7,672 6,649 7,010 6,984 6,502 -7 -15 Employee 3,691 3,793 4,446 7,808 5,761 4,231 4,863 4,412 4,230 -4 -27 Others 1,665 1,971 1,909 2,224 1,911 2,418 2,146 2,572 2,272 -12 19 Operating Profits 8,402 9,084 7,481 5,646 8,593 7,056 6,323 7,034 6,370 -9 -26 Provisions 1,457 2,022 4,116 4,758 3,681 2,250 2,379 5,939 3,256 -45 -12 PBT 6,945 7,063 3,365 888 4,912 4,807 3,943 1,095 3,114 184 -37 Taxes 2,328 2,096 59 -2,032 1,738 1,749 1,298 -1,618 1,042 -164 -40 PAT 4,617 4,967 3,306 2,919 3,174 3,058 2,645 2,713 2,072 -24 -35 Asset Quality GNPA 15,539 19,798 31,801 35,655 37,228 41,793 38,348 45,622 47,229 4 27 NNPA 9,631 12,601 21,419 23,843 24,857 28,039 24,836 27,636 28,568 3 15 GNPA (%) 1.7 2.1 3.2 3.3 3.4 3.8 3.4 3.7 4.0 34 60 NNPA (%) 1.0 1.3 2.2 2.3 2.3 2.6 2.3 2.3 2.5 20 15 PCR (Calculated, %) 38 36 33 33 33 33 35 39 40 9 628 PCR (Reported, %) 75 71 61 60 61 59 58 58 58 -21 -369 Ratios (%) Fees to Total Income 12.1 18.9 12.1 16.6 11.9 17.2 13.3 16.7 13.2 Cost to Core Income 40.6 41.1 48.5 73.3 59.4 50.0 55.3 53.2 52.4 Tax Rate 33.5 29.7 1.8 -228.9 35.4 36.4 32.9 -147.8 33.5 CASA (calculated) 29.3 29.0 28.3 27.6 26.9 26.8 26.7 27.2 27.9 Loan/Deposit 73.9 73.0 74.0 75.5 73.0 72.5 71.2 76.6 75.7 Margins (%) - Reported Yield on loans 11.3 11.1 11.1 10.6 10.5 10.4 N.A. 10.2 10.1 -8 -36 Cost of Deposits 7.0 7.1 7.1 7.1 7.1 7.1 N.A. 7.1 7.1 0 4 Margins 3.3 3.1 3.1 2.9 2.9 2.6 2.7 2.5 2.4 -3 -44 Balance Sheet (INR b) Gross Loans 939 957 1,000 1,072 1,092 1,107 1,122 1,244 1,177 -5 8 Deposits 1,270 1,312 1,351 1,420 1,496 1,527 1,576 1,623 1,553 -4 4 CASA Deposits 372 380 383 391 402 409 421 441 433 -2 8 Loan Break Up Agriculture 142 151 159 170 172 175 178 190 203 7 18 Corporate & Comm Banking 498 495 509 549 553 554 554 646 584 -10 6 Overseas loans 55 55 61 60 66 0 74 75 69 -8 4 Source: MOSL, Company
  • 6. 26 July 2014 6 Indian Bank EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY15 23.4 31.3 -25.1 FY16 28.1 37.2 -24.5 Shareholding pattern (%) Jun-14 Mar-14 Jun-13 Promoter 81.5 81.5 80.0 DII 6.5 6.1 6.0 FII 6.9 6.5 8.3 Others 5.1 5.9 5.7 Notes: FII includes depository receipts Stock performance (1-year) s
  • 7. 26 July 2014 7 Indian Bank Financials and valuations Income Statements (INR Billion) Y/E March 2014 2015E 2016E 2017E Interest Income 152.5 169.0 182.6 211.1 Interest Expense 108.9 122.9 130.7 151.1 Net Interest Income 43.6 46.1 51.8 60.0 Change (%) -3.7 5.7 12.5 15.7 Non Interest Income 13.7 12.8 14.9 16.6 Net Income 57.3 58.9 66.7 76.6 Change (%) -1.4 2.7 13.3 14.7 Operating Expenses 28.3 18.6 20.6 23.2 Pre Provision Profits 29.0 40.3 46.2 53.4 Change (%) -5.3 39.0 14.5 15.6 Provisions (excl tax) 14.2 13.4 14.1 16.3 PBT 14.8 26.9 32.1 37.1 Tax 3.2 5.4 6.4 7.3 Tax Rate (%) 21.5 19.9 20.0 19.8 Profits for Equity SH 11.3 10.9 13.1 14.9 Change (%) -26.7 -3.8 19.8 14.0 Equity Dividend (Incl tax) 2.3 2.2 2.6 3.0 Core PPP* 22.0 23.9 26.8 31.3 Change (%) -13.6 8.6 12.1 16.8 Balance Sheet (INR Billion) Y/E March 2014 2015E 2016E 2017E Equity Share Capital 4.6 4.6 4.6 4.6 Reserves & Surplus 134.1 141.3 150.1 160.3 Net Worth 138.7 145.9 154.7 165.0 Deposits 1,622.7 1,768.8 2,034.1 2,400.3 Change (%) 14.3 9.0 15.0 18.0 of which CASA Dep 440.6 503.1 574.6 656.5 Change (%) 12.4 14.2 14.2 14.2 Borrowings 49.6 58.4 62.3 66.4 Other Liabilities & Prov. 62.2 74.9 91.1 111.0 Total Liabilities 1,873.3 2,048.0 2,342.2 2,742.6 Current Assets 104.9 100.5 119.2 140.4 Investments 469.1 516.0 577.9 664.6 Change (%) 12.2 10.0 12.0 15.0 Loans 1,222.1 1,344.3 1,545.9 1,824.2 Change (%) 15.7 10.0 15.0 18.0 Fixed Assets 29.3 29.8 30.2 30.7 Other Assets 47.8 57.4 68.9 82.7 Total Assets 1,873.3 2,048.0 2,342.2 2,742.6 Asset Quality (INR Billion) Y/E March 2014 2015E 2016E 2017E GNPA 45.6 54.5 58.8 61.1 NNPA 27.6 29.9 30.2 28.8 GNPA Ratio 3.7 4.0 3.7 3.3 NNPA Ratio 2.3 2.2 2.0 1.6 PCR (Excl Tech. write off) 39.4 45.0 48.6 52.8 PCR (Incl Tech. Write off) 57.8 61.0 64.4 68.5 Ratios Y/E March 2014 2015E 2016E 2017E Spreads Analysis (%) Avg. Yield-Earning Assets 9.5 9.4 9.0 9.0 Avg. Yield on loans 10.0 10.0 9.6 9.6 Avg. Yield on Investments 8.4 8.0 7.6 7.5 Avg. Cost-Int. Bear. Liab. 7.0 7.0 6.7 6.6 Avg. Cost of Deposits 7.0 7.0 6.7 6.6 Interest Spread 2.5 2.3 2.4 2.4 Net Interest Margin 2.7 2.6 2.6 2.6 Profitability Ratios (%) RoE 10.3 9.1 10.1 10.7 RoA 0.7 0.6 0.6 0.6 Int. Expense/Int.Income 71.4 72.7 71.6 71.6 Fee Income/Net Income 14.7 15.1 15.2 15.1 Non Int. Inc./Net Income 23.9 21.8 22.3 21.6 Efficiency Ratios (%) Cost/Income* 52.9 51.8 51.8 51.7 Empl. Cost/Op. Exps. 68.0 63.5 62.0 60.9 Busi. per Empl. (Rs m) 136.9 145.8 156.2 174.0 NP per Empl. (Rs lac) 6.0 5.3 6.1 6.6 Asset-Liabilty Profile (%) Loans/Deposit Ratio 75.3 76.0 76.0 76.0 CASA Ratio 27.2 28.4 28.3 27.4 Investment/Deposit Ratio 28.9 29.2 28.4 27.7 G-Sec/Investment Ratio 81.2 82.3 84.5 86.7 CAR 12.6 12.3 11.1 9.9 Tier 1 10.2 10.0 9.1 8.2 Valuation Y/E March 2014 2015E 2016E 2017E Book Value (INR) 248.2 266.1 287.7 312.2 Change (%) 2.2 7.2 8.1 8.5 Price-BV (x) 0.6 0.6 0.5 0.5 Adjusted BV (INR) 206.5 221.1 242.2 268.8 Price-ABV (x) 0.8 0.7 0.6 0.6 EPS (Rs) 24.9 23.4 28.1 32.0 Change (%) -32.2 -6.0 19.8 14.0 Price-Earnings (x) 6.3 6.7 5.5 4.9 Dividend Per Share (INR) 4.7 4.7 5.6 6.4 Dividend Yield (%) 3.0 3.0 3.6 4.1
  • 8. 26 July 2014 8 Indian Bank Disclosures This research report has been prepared by MOSt to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies). This report is for personal information of the select recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your general information and should not be reproduced or redistributed to any other person in any form. This report does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Before acting on any advice or recommendation in this material, investors should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the investments referred to in this material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. MOSt and its affiliates are a full-service, integrated investment banking, investment management, brokerage and financing group. We and our affiliates have investment banking and other business relationships with a significant percentage of the companies covered by our Research Department Our research professionals provide important input into our investment banking and other business selection processes. Investors should assume that MOSt and/or its affiliates are seeking or will seek investment banking or other business from the company or companies that are the subject of this material and that the research professionals who were involved in preparing this material may participate in the solicitation of such business. The research professionals responsible for the preparation of this document may interact with trading desk personnel, sales personnel and other parties for the purpose of gathering, applying and interpreting market information. Our research professionals are paid in part based on the profitability of MOSt which include earnings from investment banking and other business. MOSt generally prohibits its analysts, persons reporting to analysts, and members of their households from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. Additionally, MOSt generally prohibits its analysts and persons reporting to analysts from serving as an officer, director, or advisory board member of any companies that the analysts cover. Our salespeople, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest . MOSt and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. Any statements contained in this report attributed to a third party represent MOSt’s interpretation of the data, information and/or opinions provided by that third party either publicly or through a subscription service, and such use and interpretation have not been reviewed by the third party. This Report is not intended to be a complete statement or summary of the securities, markets or developments referred to in the document. While we would endeavor to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Indian Bank  Analyst ownership of the stock No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran Email:anosh.Koppikar@motilaloswal.com Email : kadambari.balachandran@motilaloswal.com Contact(+65)68189232 Contact: (+65) 68189233 / 65249115 Office Address:21 (Suite 31),16 Collyer Quay,Singapore 04931 Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com